Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia

This publication has 26 references indexed in Scilit:

• Apolipoprotein B100 Metabolism in Autosomal-Dominant Hypercholesterolemia Related to Mutations inPCSK9
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
• Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia
  Atherosclerosis, 2004
• Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese
  Journal of Lipid Research, 2003
• Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
  Nature Genetics, 2003
• Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2 +5G>C mutation in ABCA1 gene
  Journal of Lipid Research, 2003
• Intronic mutations outside of Alu -repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia
  Human Genetics, 2002
• Phenotypic variability in familial hypercholesterolaemia: an update
  Current Opinion in Lipidology, 2002
• The molecular basis of familial hypercholesterolemia in The Netherlands
  Human Genetics, 2001
• Characterization of a Splice-Site Mutation in the Gene for the LDL Receptor Associated With an Unpredictably Severe Clinical Phenotype in English Patients With Heterozygous FH
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993